Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Vesprini

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Annals of Palliative Medicine|September 6, 2018
Radiotherapy for patients with unresected locally advanced breast cancerCaitlin Yee, Yasir Alayed, Leah Drost, et al.
The Journal of Urology|April 25, 2020
Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate CancerJay S Detsky, Alireza Fotouhi Ghiam, Alexandre Mamedov, et al.
Human Pathology|August 4, 2018
Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue typesChiyun Wang, Elan Hahn, Elzbieta Slodkowska, et al.
BMC Cancer|April 5, 2019
Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysisJonathan Klein, William Tran, Elyse Watkins, et al.
The American Journal of Surgical Pathology|May 12, 2018
PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell CarcinomaAnjelica Hodgson, Elzbieta Slodkowska, Achim Jungbluth, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 22, 2014
A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillanceMichael R Da Rosa, Laurent Milot, Linda Sugar, et al.
Practical Radiation Oncology|January 14, 2018
To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostateMerrylee McGuffin, Naila Devji, Lyann Kehoe, et al.
The Journal of Urology|August 30, 2016
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook ExperienceHima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic ReviewToni Zhong, Glenn G Fletcher, Muriel Brackstone, et al.
NPJ Precision Oncology|June 22, 2022
An appraisal of genetic testing for prostate cancer susceptibilityAmy Finch, Roderick Clark, Danny Vesprini, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Annals of Palliative Medicine|September 6, 2018
Radiotherapy for patients with unresected locally advanced breast cancerCaitlin Yee, Yasir Alayed, Leah Drost, et al.
The Journal of Urology|April 25, 2020
Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate CancerJay S Detsky, Alireza Fotouhi Ghiam, Alexandre Mamedov, et al.
Human Pathology|August 4, 2018
Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue typesChiyun Wang, Elan Hahn, Elzbieta Slodkowska, et al.
BMC Cancer|April 5, 2019
Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysisJonathan Klein, William Tran, Elyse Watkins, et al.
The American Journal of Surgical Pathology|May 12, 2018
PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell CarcinomaAnjelica Hodgson, Elzbieta Slodkowska, Achim Jungbluth, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 22, 2014
A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillanceMichael R Da Rosa, Laurent Milot, Linda Sugar, et al.
Practical Radiation Oncology|January 14, 2018
To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostateMerrylee McGuffin, Naila Devji, Lyann Kehoe, et al.
The Journal of Urology|August 30, 2016
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook ExperienceHima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic ReviewToni Zhong, Glenn G Fletcher, Muriel Brackstone, et al.
NPJ Precision Oncology|June 22, 2022
An appraisal of genetic testing for prostate cancer susceptibilityAmy Finch, Roderick Clark, Danny Vesprini, et al.
Pageof 15